Beijing Saiseng Pharmaceutical Co., Ltd. hereby notifies that the 2025 Annual Shareholders' Meeting will be held. The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
I. Basic Information of the Meeting
- Shareholders' Meeting Session: 2025 Annual Shareholders' Meeting
- Convener of the Meeting: Board of Directors
- The convening and holding of this meeting comply with the relevant provisions of the Company Law of the People's Republic of China, the Shenzhen Stock Exchange GEM Listing Rules, the Shenzhen Stock Exchange Self-Regulatory Guidelines No. 2 for GEM Listed Companies, and the Articles of Association.
- Meeting Time:
- (1) On-site Meeting Time: April 23, 2026, at 14:30
- (2) Online Voting Time: Specific times for online voting through the Shenzhen Stock Exchange system are April 23, 2026, from 9:15-9:25, 9:30-11:30, and 13:00-15:00; voting through the Shenzhen Stock Exchange Internet voting system can occur at any time from 9:15 to 15:00 on April 23, 2026.
- Method of Meeting: Combination of on-site voting and online voting.
- Record Date for Shareholding: April 16, 2026
- Attendees:
- (1) All shareholders registered with China Securities Depository and Clearing Corporation Limited Shenzhen Branch by 15:00 on April 16, 2026, have the right to attend the meeting. Shareholders unable to attend in person may appoint a proxy to attend and vote on their behalf; the proxy does not need to be a shareholder of the company (proxy authorization format is attached).
- (2) Company directors and senior management.
- (3) Lawyers hired by the company.
- (4) Other relevant personnel.
- Meeting Location: No. 8, Xingsheng Street, Beijing Economic and Technological Development Zone, Beijing.
II. Matters for Discussion at the Meeting
- Proposal Coding Table for the Shareholders' Meeting
| Proposal Code | Proposal Name | Proposal Type | Remarks |
|---|---|---|---|
| 100 | Total Proposal: All proposals except cumulative voting | Non-cumulative vote | √ |
| 1.00 | Proposal on the Board of Directors' 2025 Work Report | Non-cumulative vote | √ |
| 2.00 | Proposal on the 2025 Financial Settlement Report | Non-cumulative vote | √ |
| 3.00 | Proposal on the 2025 Annual Report and Summary | Non-cumulative vote | √ |
| 4.00 | Proposal on the 2025 Profit Distribution Plan | Non-cumulative vote | √ |
| 5.00 | Proposal on the 2026 Compensation Plan for Directors | Non-cumulative vote | √ |
| 6.00 | Proposal on Establishing the Compensation Management System | Non-cumulative vote | √ |
| 7.00 | Proposal to Reappoint Crowe Horwath as the 2026 Auditor | Non-cumulative vote | √ |